Experimental Study of a New Vascular Graft Prebonded with Antibiotic: Healing, Toxicity, and Antibiotic Retention

Annals of Vascular Surgery

Volumn 21, Issue 5, 2007, Pages 603-610

  Javerliat, Isabelle ^a,b   Goëau Brissonnière, Olivier ^a,b   Bruneval, Patrick ^c   Coggia, Marc ^a,b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAMANDOLE; RIFAMPICIN; TOBRAMYCIN;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL GRAFT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HISTOPATHOLOGY; INFECTION RESISTANCE; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MALE; NONHUMAN; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ANIMALS; ANTI-BACTERIAL AGENTS; AORTA, ABDOMINAL; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; DOGS; GELATIN; GIANT CELLS; KIDNEY; LIVER; MALE; MODELS, ANIMAL; POLYESTERS; PROSTHESIS DESIGN; PROSTHESIS-RELATED INFECTIONS; RIFAMPIN; SURFACE PROPERTIES; THROMBOSIS; TIME FACTORS; TOBRAMYCIN; TUNICA INTIMA; WOUND HEALING;

EID: 34548262588     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2007.06.005     Document Type: Article

References (15)

1. Seeger J.M., Petrus H.A., Welborn M.B., Ozaki C.K., Flynn T.C., and Huber T.S. Long term outcome after treatment of aortic graft infection with staged extra-anatomic bypass grafting and aortic graft removal. J Vasc Surg 32 (2000) 451-461
2. Yeager R.A., Taylor L.M., Moneta G.L., et al. Improved results with conventional management of infrarenal aortic infection. J Vasc Surg 30 (1999) 76-83
3. Hallett J.W., Marshall D.M., Petterson T.M., et al. Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg 25 (1997) 277-286
4. Gahtan V., Esses G.E., Bandyk D.F., Nelson R.T., Dupont E., and Mills J. Antistaphylococcal activity of rifampin-bonded gelatin-impregnated dacron grafts. J Surg Res 58 (1995) 105-110
5. Coggia M., Goëau-Brissonnière O., Leflon V., Nicolas-Chanoine M.H., and Péchère J.C. Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft. Ann Vasc Surg 15 (2001) 421-429
6. Goëau-Brissonnière O., Leport C., Bacourt F., Lebrault C., Comte R., and Pechere J.C. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed dacron graft. Ann Vasc Surg 5 (1991) 408-412
7. Kunin C.M., Brandt D., and Wood H. Bacteriologic studies of rifampin, a new semisynthetic antibiotic. J Infect Dis 119 (1969) 132-137
8. Mandell G.L., and Keit Vest T. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. J Infect Dis 125 (1972) 486-490
9. Thornsberry C., Hill B.C., Swenson J.M., and McDougal L.K. Rifampin: spectrum of antibacterial activity. Rev Infect Dis 5 (1983) S412-S417
10. Malassiney P., Goëau-Brissonnière O., Coggia M., and Pechère J.C. Rifampicin loading of vascular grafts. J Antimicrob Chemother 37 (1996) 1121-1129
11. Leblebicioglu H., Sencan I., Gunaydin M., Esen S., Eroglu C., and Sunbul M. Elution of vancomycin and tobramycin bonded to vascular grafts. J Chemother 11 (1999) 46-49
12. Grosset J., and Leventis S. Adverse effects of rifampin. Rev Infect Dis 5 (1983) S440-S450
13. Lachapelle K., Graham A.M., and Symes J.F. Antibacterial activity, antibiotic retention, and infection resistance of a rifampin-impregnated gelatin-sealed dacron graft. J Vasc Surg 19 (1994) 675-682
14. Lortholary O., Tod M., Cohen Y., and Petitjean O. Aminoglycosides. Med Clin North Am 79 (1995) 761-787
15. Goëau-Brissonnière O.A., Fabre D., Leflon-Guibout V., Di Centa I., Nicolas-Chanoine M.H., and Coggia M. Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J Vasc Surg 35 (2002) 1260-1263